DHODH and multiple sclerosis: While BQ is not an approved medication, two FDA-approved low potency DHODH inhibitors (leflunomide, teriflunomide) are effective in treating autoimmune conditions such as rheumatoid arthritis and multiple sclerosis and act to decrease the activity of auto-reactive T-lymphocytes 56–58.